For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Oruka Therapeutics Inc (NASDAQ: ORKA) closed at $30.31 in the last session, up 4.09% from day before closing price of $29.12. In other words, the price has increased by $4.09 from its previous closing price. On the day, 0.56 million shares were traded. ORKA stock price reached its highest trading level at $30.81 during the session, while it also had its lowest trading level at $29.09.
Ratios:
We take a closer look at ORKA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.94 and its Current Ratio is at 16.94. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Piper Sandler on December 18, 2025, initiated with a Overweight rating and assigned the stock a target price of $75.
On November 13, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $45.
On October 27, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $60.Guggenheim initiated its Buy rating on October 27, 2025, with a $60 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’25 when Goncalves Joana sold 7,000 shares for $30.61 per share. The transaction valued at 214,293 led to the insider holds 1,518 shares of the business.
JOANA GONCALVES bought 28,000 shares of ORKA for $788,200 on Dec 19 ’25. On Feb 14 ’25, another insider, Venrock Healthcare Capital Par, who serves as the 10% Owner of the company, bought 88,794 shares for $11.44 each. As a result, the insider paid 1,015,803 and bolstered with 4,148,428 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORKA now has a Market Capitalization of 1467283840 and an Enterprise Value of 1122971776.
Stock Price History:
The Beta on a monthly basis for ORKA is -0.37, which has changed by 0.45651126 over the last 52 weeks, in comparison to a change of 0.15196204 over the same period for the S&P500. Over the past 52 weeks, ORKA has reached a high of $32.64, while it has fallen to a 52-week low of $5.49. The 50-Day Moving Average of the stock is 4.55%, while the 200-Day Moving Average is calculated to be 73.42%.
Shares Statistics:
According to the various share statistics, ORKA traded on average about 520.38K shares per day over the past 3-months and 955190 shares per day over the past 10 days. A total of 48.38M shares are outstanding, with a floating share count of 42.67M. Insiders hold about 11.86% of the company’s shares, while institutions hold 85.60% stake in the company. Shares short for ORKA as of 1765756800 were 5830860 with a Short Ratio of 11.21, compared to 1763078400 on 5249677. Therefore, it implies a Short% of Shares Outstanding of 5830860 and a Short% of Float of 16.98.
Earnings Estimates
The stock of Oruka Therapeutics Inc (ORKA) is currently drawing attention from 7.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.64, with high estimates of -$0.55 and low estimates of -$0.73.
Analysts are recommending an EPS of between -$1.52 and -$2.65 for the fiscal current year, implying an average EPS of -$2.09. EPS for the following year is -$2.4, with 7.0 analysts recommending between -$2.03 and -$3.15.
